Ying J. Hitchcock
Rating: 4.8 of 5
( out of 153 reviews )

Ying J. Hitchcock, MD, FASTRO

Languages spoken: English, Mandarin Chinese

Clinical Locations

Primary Location

Farmington Health Center

165 N. University Ave.
Farmington , UT 84025
801-213-3200
Get Directions

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
1950 Circle of Hope
Salt Lake City , UT 84112
801-581-2396
Get Directions

  • Dr. Ying Hitchcock received a medical degree from the Peking Union Medical College Graduate School in Beijing, China, where she specialized in head and neck surgery. She completed an internship in general surgery at the State University of New York at Buffalo Graduate Medical-Dental Education Consortium and a residency in radiation oncology at the Roswell Park Cancer Institute, also in Buffalo.

    Ying Hitchcock, MD, is a professor in the Department of Radiation Oncology, specializing in head and neck, lung, and skin cancers and in adult soft tissue sarcomas. She is also a Principle Investigator for Huntsman Cancer Institute ,Radiation Therapy Oncology Group (RTOG)/NGR, and multi-institutional studies.

    Dr. Hitchcock has served as the department’s Residency Program Director 2003-2012. She has received the Outstanding Teacher of the Year Award from the Association of Residents in Radiation Oncology (ARRO) twice, for the 2006-2007 and 2008-2009 academic years.

    DR. Hitchcock currently is Medical Director and Chief of Value Officer of Department Radiation Oncology, Huntsman Cancer Hospital, University of Utah.

    Specialties

    Board Certification

    American Board of Radiology (Radiation Oncology)

    Patient Rating

    Rating: 4.8 out of 5
    4.8 /5
    ( out of 153 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    October 18, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Hitchcock is truly admirable. She patiently explained to us about my conditions and laid out the various treatment plans, including the pro-cons and possible side-effects for each of them. During the process of the radiation treatment, she monitored my progress very closely and was always encouraging. I really appreciate her commitment to providing the best experience I could have imagined. Her team also showed exceptional kindness and professionalism.

    July 09, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Thorough and caring. Made me feel like we have a plan and it will work.

    June 11, 2025
    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Dr. Hitchcock is a fantastic care provider

    May 29, 2025
    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Knowledge ,with concern for the patient and a willing smile wins every time

    May 23, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Very professional

    March 12, 2025
    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Dr. Hitchcock is very good at clearly explaining the needed care and procedures for treatment. She answers all questions and includes you in all planning decisions.

    October 16, 2024
    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    The fact that she consulted with the top hospitals in the Country to find the best treatment plan spoke volumes!

    September 28, 2024
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Very knowledgable and caring. Always putting patients first. Great experience.

    September 26, 2024
    FARMINGTON HEALTH CENTER
    Rating: 5 out of 5

    Dr Hitchcock is the best! She explains e writhing in a clear manner and makes you feel part of the treatment plan.

  • Dr. Ying Hitchcock received a medical degree from the Peking Union Medical College Graduate School in Beijing, China, where she specialized in head and neck surgery. She completed an internship in general surgery at the State University of New York at Buffalo Graduate Medical-Dental Education Consortium and a residency in radiation oncology at the Roswell Park Cancer Institute, also in Buffalo.

    Ying Hitchcock, MD, is a professor in the Department of Radiation Oncology, specializing in head and neck, lung, and skin cancers and in adult soft tissue sarcomas. She is also a Principle Investigator for Huntsman Cancer Institute ,Radiation Therapy Oncology Group (RTOG)/NGR, and multi-institutional studies.

    Dr. Hitchcock has served as the department’s Residency Program Director 2003-2012. She has received the Outstanding Teacher of the Year Award from the Association of Residents in Radiation Oncology (ARRO) twice, for the 2006-2007 and 2008-2009 academic years.

    DR. Hitchcock currently is Medical Director and Chief of Value Officer of Department Radiation Oncology, Huntsman Cancer Hospital, University of Utah.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Professor (Clinical)
    Board Certification
    American Board of Radiology (Radiation Oncology)

    Education history

    Residency Radiation Oncology - Roswell Park Cancer Institute Resident
    Internship General Surgery - SUNY - Buffalo Intern
    Professional Medical Head & Neck Surgery - Peking Union Medical College M.D.
    Graduate Training Medicine - The 4th Military Medical University M.S.
    Residency Otolaryngology - The 4th Military Medical University Resident
    Undergraduate Medicine - The 4th Military Medical University B.S.

    Selected Publications

    Journal Article

    1. Tang LL, Huang CL, Lin SJ, Le QT, OSullivan B, Yom SS, Huang SH, Chan AW, Lee N, Pan JJ, Mejia MBA, Ahn YC, Wong KCW, McDowell L, Orlandi E, Friborg J, Chen YP, Yasuda K, Kodaira T, Whitley AC, King AD, Prajogi GB, Hahn E, Lin JC, Kiyota N, Lee V, Ji PJHitchcock Y, Hoebers F, Blanchard P, Moon SH, Wan Ishak WZ, Harrington KJ, Yang KY, Colevas AD, Lee A, Hu CS, Rosenthal D, Siddiqui F, Langendijk JA, Lang JY, Yi JL, Shen LF, Li JB, Liu LZ, Lee AWM, Mai HQ, Yang MK, Sun Y, Chua MLK, Ma J (2025). Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas. . Lancet Oncol, 26(9), e477-e487.
    2. Tang LL, Huang CL, Lin SJ, Le QT, OSullivan B, Yom SS, Huang SH, Chan AW, Lee N, Pan JJ, Mejia MBA, Ahn YC, Wong KCW, McDowell L, Orlandi E, Friborg J, Chen YP, Yasuda K, Kodaira T, Whitley AC, King AD, Prajogi GB, Hahn E, Lin JC, Kiyota N, Lee V, Ji PJ, Hitchcock Y, Hoebers F, Blanchard P, Moon SH, Wan Ishak WZ, Harrington KJ, Yang KY, Colevas AD, Lee A, Hu CS, Rosenthal D, Siddiqui F, Langendijk JA, Lang JY, Yi JL, Shen LF, Li JB, Liu LZ, Lee AWM, Mai HQ, Yang MK, Sun Y, Chua MLK, Ma J (2025). Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas. Lancet Oncol, 26(9), e488-e498.
    3. Colevas AD, Cmelak AJ, Pfister DG, Spencer S, Adkins D, Birkeland AC, Brizel DM, Busse PM, Caudell JJ, Durm G, Fakhry C, Galloway T, Geiger JL, Gillison ML, Glastonbury C, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Juloori A, Kase M, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Price K, Rocco JW, Rodriguez CP, Schwartz D, Shah JP, Sher D, John MS, Wang H, Weinstein G, Worden F, Bruce JY, Yom SS, Zhen W, Montgomery S, Darlow SD (2025). NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw, 23(2), 2-11. (Read full publication)
    4. Kim SE, Roberts JA, Kholmovski EG, Hitchcock Y, Anzai Y (2024). T1 mapping for Head and Neck Cancer Patients undergoing Chemoradiotherapy: Feasibility of 3D Stack of Star Imaging. Magn Reson Imaging, 112, 38-46. (Read full publication)
    5. Roberts J, Kim SE, Kholmovski EG, Hitchcock Y, Richards TJ, Anzai Y (2023). The arterial input function: Spatial dependence within the imaging volume and its influence on 3D quantitative dynamic contrast-enhanced MRI for head and neck cancer. Magn Reson Imaging, 101, 40-46. (Read full publication)
    6. Ryu S, Deshmukh S, Timmerman RD, Movsas B, Gerszten P, Yin FF, Dicker A, Abraham CD, Zhong J, Shiao SL, Tuli R, Desai A, Mell LK, Iyengar P, Hitchcock YJ, Allen AM, Burton S, Brown D, Sharp HJ, Dunlap NE, Siddiqui MS, Chen TH, Pugh SL, Kachnic LA (2023). Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. JAMA Oncol, 9(6), 800-807. (Read full publication)
    7. Wang D, Harris J, Kraybill WG, Eisenberg B, Kirsch DG, Ettinger DS, Kane JM 3rd, Barry PN, Naghavi A, Freeman CR, Chen YL, Hitchcock YJ, Bedi M, Salerno KE, Severin D, Godette KD, Larrier NA, Curran WJ Jr, Torres-Saavedra PA, Lucas DR (2023). Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials. JAMA Oncol, 9(5), 646-655. (Read full publication)
    8. Rock CB, Hutten RJ, Weil CR, Lloyd S, Kerrigan KC, Cannon RB, Hitchcock YJ (2022). Survival outcomes for patients with T3N0M0 squamous cell carcinoma of the glottis treated with definitive radiation alone versus chemoradiation. Head Neck, 45(2), 431-438. (Read full publication)
    9. Hutten RJ, Nelson G, Sarkar V, Johnson SB, Tao R, Hitchcock Y, Chan J, Schroeder J, Kokeny K (2022). Feasibility and Clinical Utility of a Workflow Interfacing Radiation Oncology Lung Stereotactic Body Radiation Therapy Treatment Planning and Diagnostic Radiology. Pract Radiat Oncol, 12(6), e512-e516. (Read full publication)
    10. Katsoulakis E, Kudner R, Chapman C, Park J, Puckett L, Solanki A, Kapoor R, Hagan M, Kelly M, Palta J, Tishler R, Hitchcock Y, Chera B, Feygelman V, Walker G, Sher D, Kujundzic K, Wilson E, Dawes S, Yom SS, Harrison L (2022). Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Pract Radiat Oncol, 12(5), 409-423. (Read full publication)
    11. Fenlon JB, Hutten RJ, Weil CR, Lloyd S, Cannon DM, Kerrigan K, Cannon RB, Hitchcock YJ (2021). Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins. Head Neck, 44(3), 606-614. (Read full publication)
    12. Caudell JJ, Gillison ML, Maghami E, Spencer S, Pfister DG, Adkins D, Birkeland AC, Brizel DM, Busse PM, Cmelak AJ, Colevas AD, Eisele DW, Galloway T, Geiger JL, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Mell LK, Mittal BB, Pinto HA, Rocco JW, Rodriguez CP, Savvides PS, Schwartz D, Shah JP, Sher D, St John M, Weber RS, Weinstein G, Worden F, Yang Bruce J, Yom SS, Zhen W, Burns JL, Darlow SD (2022). NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022. J Natl Compr Canc Netw, 20(3), 224-234. (Read full publication)
    13. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy CB, Tao R, Hitchcock YJ, Kokeny KE, Salter BJ (2020). Erratum: "Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT" [Med. Phys. (2020)]. Med Phys, 48(1), 533. (Read full publication)
    14. Sarkar V, Lloyd S, Paxton A, Dial C, Rassiah P, Szegedi MW, Hitchcock YJ, Salter BJ (2021). Evaluation of the dosimetric impact of changes in shoulder position on target coverage for spine SBRT to metastases in the lower cervical spine region. J Radiosurg SBRT, 7(4), 321-328. (Read full publication)
    15. Hendrickson PG, Luo Y, Kohlmann W, Schiffman J, Maese L, Bishop AJ, Lloyd S, Kokeny KE, Hitchcock YJ, Poppe MM, Gaffney DK, Tao R (2020). Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med, 9(21), 7954-7963. (Read full publication)
    16. Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS (2020). Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Radiother Oncol, 151, 314-321. (Read full publication)
    17. Sarkar V, Szegedi M, Paxton A, Nelson G, Rassiah-Szegedi P, Reddy CB, Tao R, Hitchcock YJ, Kokeny KE, Salter BJ (2020). Preliminary clinical experience with Calypso anchored beacons for tumor tracking in lung SBRT. Med Phys, 47(9), 4407-4415. (Read full publication)
    18. Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS (2020). Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement. Int J Radiat Oncol Biol Phys, 107(4), 618-627. (Read full publication)
    19. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD (2020). Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(7), 873-898. (Read full publication)
    20. Truong A, Hyngstrom JR, Andtbacka RHI, Noyes RD, Wright M, Snyder J, Winters A, Sause WT, Grossmann KF, Khong HT, Bowen GM, Hitchcock YJ, Grossman D, Bowles TL (2019). Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node status. Melanoma Res, 30(2), 173-178. (Read full publication)
    21. Aylward A, Park J, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Rowe K, Snyder J, Deshmukh V, Newman M, Wan Y, Fraser A, Smith K, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2020). Individualized prediction of late-onset dysphagia in head and neck cancer survivors. Head Neck, 42(4), 708-718. (Read full publication)
    22. Sarkar V, Paxton A, Rassiah P, Kokeny KE, Hitchcock YJ, Salter BJ (2020). Evaluation of dose distribution differences from five algorithms implemented in three commercial treatment planning systems for lung SBRT. J Radiosurg SBRT, 7(1), 57-66. (Read full publication)
    23. Ager BJ, Wells SM, Gruhl JD, Stoddard GJ, Tao R, Kokeny KE, Hitchcock YJ (2019). Stereotactic body radiotherapy versus percutaneous local tumor ablation for early-stage non-small cell lung cancer. Lung Cancer, 138, 6-12. (Read full publication)
    24. Wells S, Ager B, Hitchcock YJ, Poppe MM (2019). The radiation dose-response of non-retroperitoneal soft tissue sarcoma with positive margins: An NCDB analysis. J Surg Oncol, 120(8), 1476-1485. (Read full publication)
    25. Aylward A, Abdelaziz S, Hunt JP, Buchmann LO, Cannon RB, Lloyd S, Hitchcock Y, Hashibe M, Monroe MM (2019). Rates of Dysphagia-Related Diagnoses in Long-Term Survivors of Head and Neck Cancers. Otolaryngol Head Neck Surg, 161(4), 643-651. (Read full publication)
    26. Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt JP (2019). Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database. Head Neck, 41(6), 1873-1879. (Read full publication)
    27. Tward JD, Poppe MM, Hitchcock YJ, ONeil B, Albertson DJ, Shrieve DC (2018). Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer Med, 7(12), 6030-6039. (Read full publication)
    28. Orton A, Boothe D, Evans D, Lloyd S, Monroe MM, Jensen R, Shrieve DC, Hitchcock YJ (2017). Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database. Neurosurgery, 83(5), 940-947. (Read full publication)
    29. Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon RB (2018). Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database. Oral Oncol, 85, 1-7. (Read full publication)
    30. Cannon RB, Carpenter PS, Boothe D, Buchmann LO, Hunt JP, Lloyd S, Hitchcock YJ, Houlton JJ, Weis JR, Shepherd HM, Monroe MM (2018). Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis. Otolaryngol Head Neck Surg, 159(3), 473-483. (Read full publication)
    31. Kokeny KE, Francis S, Tao R, Hitchcock YJ (2018). Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters. J Thorac Dis, 10(Suppl 17), S2097-S2099. (Read full publication)
    32. Terakedis BE, Hunt JP, Buchmann LO, Avizonis VN, Anker CJ, Hitchcock YJ (2014). The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland. Am J Clin Oncol, 40(3), 323-328. (Read full publication)
    33. Wynn D, Merriman J, Patel AB, Hitchcock YJ, Garrido-Laguna I, Renner D, Clardy SL (2016). Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue. Clin Neurol Neurosurg, 149, 11-4. (Read full publication)
    34. Zang J, Li C, Zhao LN, Wang JH, Xu M, Luo SQ, Hitchcock YJ, Shi M (2016). Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China. Medicine (Baltimore), 95(21), e3794. (Read full publication)
    35. Orton A, Boothe D, Gan M, Monroe MM, Hitchcock YJ, Lloyd S (2016). The "decay" of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012. Brachytherapy, 15(6), 851-858. (Read full publication)
    36. Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK, Dundas G, Kirsch DG (2015). Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial. J Clin Oncol, 33(20), 2231-8. (Read full publication)
    37. Chen LA, Anker CJ, Hunt JP, Buchmann LO, Grossmann KF, Boucher K, Fang LM, Shrieve DC, Hitchcock YJ (2015). Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience. Cancer Med, 4(5), 651-60. (Read full publication)
    38. Zang J, Li C, Luo SQ, Wang JH, Xu M, Zhao LN, Li WW, Yang H, Xiao F, Hitchcock YJ, Shi M (2015). Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience. Ann Hematol, 94(4), 583-91. (Read full publication)
    39. Chen AC, Anker CJ, Hunt JP, Buchmann LO, Grossmann KF, Boucher K, Fang LC, Shrieve DC, Hitchcock YJ (2015). Clinical Outcomes Associated with Evolving Treatment Modalities and Radiation Techniques for Base of Tongue Carcinoma: Thirty Years of Institutional Experience. Cancer Med, 4(5), 651-60.
    40. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M (2014). Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw, 12(10), 1454-87. (Read full publication)
    41. Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC (2014). Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp. J Am Acad Dermatol, 70(3), 435-42. (Read full publication)
    42. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA (2014). RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol, 4(2), 76-81. (Read full publication)
    43. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M (2013). Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw, 11(8), 917-23. (Read full publication)
    44. Sarkar V, Wang B, Hinkle J, Gonzalez VJ, Hitchcock YJ, Rassiah-Szegedi P, Joshi S, Salter BJ (2012). Dosimetric evaluation of a "virtual" image-guidance alternative to explicit 6 degree of freedom robotic couch correction. Pract Radiat Oncol, 2(2), 122-37. (Read full publication)
    45. Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F (2012). Mucosal melanoma of the head and neck. J Natl Compr Canc Netw, 10(3), 320-38. (Read full publication)
    46. Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, Gaffney D (2012). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiat Oncol, 7, 64. (Read full publication)
    47. Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Hitchcock YJ, Wolfson AH, DeLaney TF (2011). Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists. Int J Radiat Oncol Biol Phys, 81(5), e775-80. (Read full publication)
    48. Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ (2011). IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys, 81(5), e845-52. (Read full publication)
    49. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Kirsch DG, Hitchcock, YJ, Wolfson AH, DeLaney TF (2011). RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomograhic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies. Int J Radiat Oncol Biol Phys, 81(4), e525-8.
    50. Sampath S, Schultheiss TE, Hitchcock YJ, Randall RL, Shrieve DC, Wong JY (2011). Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys, 81(2), 498-505. (Read full publication)
    51. Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA (2011). RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. Int J Radiat Oncol Biol Phys, 81(2), S131-S132. (Read full publication)
    52. Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F (2011). Head and neck cancers. J Natl Compr Canc Netw, 9(6), 596-650. (Read full publication)
    53. Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD (2011). Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck, 33(5), 645-9. (Read full publication)
    54. Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY (2010). Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol, 101(5), 345-50. (Read full publication)
    55. Anker CJ, Wang B, Tobler M, Chapek J, Shrieve DC, Hitchcock YJ, Salter BJ (2010). Evaluation of fluence-smoothing feature for three IMRT planning systems. J Appl Clin Med Phys, 11(2), 3035. (Read full publication)
    56. Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA (2009). Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med, 50(8), 1205-13. (Read full publication)
    57. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2008). Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys, 73(3), 779-88. (Read full publication)
    58. Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC (2009). Relative contributions of radiation and cisplatin-based chemotherapy to seneorineural hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys, 73(3), 779-88.
    59. Chen J, Tward JD, Shrieve DC, Hitchcock YJ (2008). Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002. Am J Clin Oncol, 31(5), 460-4. (Read full publication)
    60. Skidmore T, Lee C, Abbott T, Wiggins R, Anderson G, Hitchcock YJ (2008). Progressive Bone Loss Gorhma's Disease. Ear Nose Throat J, 87(6), E4-7.
    61. Chen J, Shrieve DC, Hitchcock YJ (2008). Comparison of cervical esophagus dose-volumes for three radiotherapy techniques for head and neck cancer. Radiother Oncol, 87(2), 274-80. (Read full publication)
    62. Wallace S, Pilon A, Kwok P, Messner LV, Hitchcock YJ (2008). Ophthalmic manifestations of an undifferentiated sinonasal carcinoma. Optom Vis Sci, 85(4), 226-9.
    63. Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD (2008). The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. J Clin Endocrinol Metab, 93(2), 504-15. (Read full publication)
    64. Hitchcock YJ, Bentz BG, Sharma PK, Fang C, Tward JD, Pappas L, Chen J, Hayes JK, Shrieve DC (2007). Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers. Otolaryngol Head Neck Surg, 137(3), 422-7. (Read full publication)
    65. Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, Fang LC, Hayes JK, Shrieve DC, Hitchcock YJ (2007). Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck, 29(4), 362-9. (Read full publication)
    66. Hitchcock YJ, Chen J, Sharma P, Moeller J, et al (2005). Iridium-192 interstitial brachytherapy for squamous cell carcinoma of the oral tongue. Brachytherapy, 4, 96.
    67. Randall RL, Schabel KL, Hitchcock YJ, Joyner DE, Albritton KH (2005). Diagnosis and management of synovial sarcoma. Curr Treat Options Oncol, 6(6), 449-59.
    68. Pidhorecky I, Lee RJ, Proulx G, Kollmorgen DR, Jia CY, Driscoll DL, Kraybill WG, Gibbs JF (2001). Risk factors for nodal recurrence after lymphadenectomy for melanoma. Ann Surg Oncol, 8(2), 109-15.
    69. Warnakulasuriya S, Jia CY, Johnson N, Houghton J (2000). p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy. J Pathol, 191(1), 33-38.
    70. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia CY, Kraybill WG (2000). Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys, 46(2), 467-474.
    71. Tu GY, Tang PZ, Jia CY (1997). Horizontovertical laryngectomy for supraglottic carcinoma. Otolaryngol Head Neck Surg, 117(3 pt 1), 280-286.
    72. Jia CY, Want J, Qian W, et al (1994). The relationship between amplication of c-myc oncogene and squamous cell carcinoma of the larynx. Clin Otolaryngol, 8, 70-71.
    73. Tu GY, Jia CY (1994). How do I do it? Surgical approach for parapharyngeal space recurrence of the nasopharyngeal carinoma after failure of high dose radiation therapy. Arch Otolaryngol Head Neck Surg, 1, 191-192.

    Book Chapter

    1. Gaffney DK, Shrieve DC, Anker CJ, Buyyounouski MK, Kong FM, Hitchcock YJ, Tward JD (12/19/2012). Paranasal Sinus Cancer; Oral Cavity Cancer. In Radiation Oncology: Imaging and Treatment (p. 808). Amirsys.

    Conference Proceedings

    1. Hitchcock YJ, Kurtz A, Zhou H, Randall L (2005). Radiation induced sarcomas in long term cancer survivors. 11th Annual Connective Tissue Oncology Society, Boca Raton: 11th Annual Connective Tissue Oncology Society.
    2. Hitchcock YJ, Chen J, Sharma P, Moeller J, et al (2005). Iridium-192 interstitial brachytherapy for squamous cell carcinoma of the oral tongue. The 26th Annual Meeting of the American Brachytherapy Society, San Francisco: Brachytherapy.
    3. Hitchcock YJ, Bentz B, Fang C, Shrieve D, Sharma P (2005). Does chemotherapy change the role of planned neck dissection? - Single instituion experience in neck management of squamous cell carcinoma of the base of tongue treated with definitive radition therapy with or without chemotherapy. Radiological Society of North America, Radiological Society of North America.
    4. Hitchcock YJ, Chern Shyh-Shi, Chapek J, Williams G, Albritton K, Randall L, Gaffney D, Leavitt D (2004). Intensity modulated radiotherapy for large abdominal or retroperitoneal connective tissue tumors. 10th Annual Connective Tissue Oncology Society, Montreal, Quebec: 10th Annual Connective Tissue Oncology Society in Montreal.
    5. Hitchcock YJ, Bentz B, Jensen R, Sharma P (2004). Second high-grade sarcoma of the mandible within prophylactic cranial irradiation field in a long-term survivor of childhood acute lymphocytic leukemia. 10th Annual Connective Tissue Oncology Society, Montreal, Quebec: 10th Annual Connective Tissue Oncology Society in Montreal.

    Letter

    1. Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Delaney TF, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH (2012). In Reply to O'Sullivan et al. [Letter to the editor]. Int J Radiat Oncol Biol Phys, 84(2), 307-8. (Read full publication)
    2. Hitchcock YJ, Proulx GM, Stomper PC (2002). Contrast-enhanced MRI for the assessment of local recurrence after breast conservation. [Letter to the editor]. Am J Clin Oncol, 25(4), 428-9. (Read full publication)

    Abstract

    1. Salter BJ, Anker CJ, Tobler M, Hitchcock YJ (2007). Optimization of IMRT fluence-map smoothing can result in improved IMRT plans [Abstract]. International Journal of Radiation Oncology Biology Physics, 69(3), S681.
    2. Hitchcock YJ, Macdonald K, Lessnick S, Chen L, Chen J, Randall L (2007). Alveolar soft part sarcoma - Demographic, clinical and pathologic predictors of survival from the surveillance, epidemiology and end results (SEER) database [Abstract]. International Journal of Radation Oncology Biology Physics, 69(3), S754-55.
    3. Tward JD, Szabo A, Orlandi R, Dahlstrom L, Shrieve DC, Hitchcock YJ (2006). Relative contributions of Radiation and platinum-based chemotherapy to sensorineural hearing loss in head and neck cancer patients [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S188.
    4. Hitchcock YJ, Morton K, Tward JD, Hoffman JM, Sharma P, Bentz B, Shrieve DC (2006). The Application of [FDG] PET/CT in treatment planning and response evaluation for patients undergoing radiotherapy for head and neck cancer [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S443-434.
    5. Chen J, Shrieve DC, Hitchcock YJ (2006). Comparison of cervial esophagus dose-volumes and three radiotherapy techniques for head and neck cancer [Abstract]. International Journal for Radiation Oncology Biology Physics, 66(3), S432-433.
    6. Brow AP, Tward JD, Shrieve DC, Hitchcock YJ (2006). The risk of development and factors affecting the pattern of secondary cancers following thyroid cancer diagnosis [Abstract]. International Journal of Radiation Oncology Biology Physics, 66(3), S434.
    7. Hitchcock YJ, Proulx G (2001). Renal function after definitive radiation therapy for pancreatic cancer [Abstract]. International Journal of Radiation Oncology Biology Physics, 51(2278a), 369.
    8. Lee RJ, Gibbs JF, Kollmorgen DR, Proulx GM, Jia CY, Driscoll DL, Kraybill WG (1998). Prognostic factors in patients undergoing lymph node dissection for node-positive melanoma: implication for adjuvant radiotherapy. [Abstract]. International Journal of Radiation Oncology, Biology, and Physics, 42, 385.

    Other

    1. Jia CY (1995). The relation between Myc gene family and had and neck cancer. (19, pp. 4-6).